SLNO
Soleno Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.04x
- Net debt / EBITDA
- -1.25x
Liquidity & coverage
- Current ratio
- 5.62x
- Quick ratio
- 5.32x
- Cash ratio
- 4.40x
- Interest coverage
- 16.23x
- EBITDA / interest
- 18.97x
- Working capital
- $268.3M
Cash & dividend
- FCF / debt
- 23.97x
- Cash flow / debt
- 23.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026